Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Tumors Lymphomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01168752
What this trial is testing

Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma

Who this might be right for
CancerNeoplasmsSolid Tumors+1 more
Debiopharm International SA 81
Early research (Phase 1)Study completedNCT03010982
What this trial is testing

Open-Label, Multi-Center, Two-Part, Ph1 Study to Characterize the PKs of an Intravenous Micro-Dose of [14C]-Tazemetostat (EPZ 6438) and the ADME of an Oral [14C]-Labeled Dose of Tazemetostat in Subjects With B-Cell Lymphomas or Adv Solid Tumors

Who this might be right for
Diffuse Large B Cell LymphomaPrimary Mediastinal LymphomaMantle-Cell Lymphoma+3 more
Epizyme, Inc. 3
Early research (Phase 1)Study completedNCT03082209
What this trial is testing

The Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies

Who this might be right for
Advanced Solid TumorsCancerHematologic Malignancies
AbbVie 153
Testing effectiveness (Phase 2)Active Not RecruitingNCT04195555
What this trial is testing

Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Recurrent EpendymomaRecurrent Ewing SarcomaRecurrent Hepatoblastoma+30 more
National Cancer Institute (NCI) 3
Early research (Phase 1)Looking for participantsNCT07195916
What this trial is testing

Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Solid TumorsHematologic Malignancies
Incyte Corporation 280
Early research (Phase 1)Ended earlyNCT00955292
What this trial is testing

Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid TumorsLymphoma
Cylene Pharmaceuticals 12
Early research (Phase 1)Study completedNCT03188965
What this trial is testing

First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas

Who this might be right for
Advanced Solid TumorNon-Hodgkin's LymphomaMantle Cell Lymphoma
Bayer 229
Early research (Phase 1)Ended earlyNCT03172936
What this trial is testing

Study of the Safety and Efficacy of MIW815 With PDR001 in Patients With Advanced/Metastatic Solid Tumors or Lymphomas

Who this might be right for
Solid Tumors and Lymphomas
Novartis Pharmaceuticals 106
Early research (Phase 1)Ended earlyNCT02683395
What this trial is testing

PLX51107 in Advanced Malignancies

Who this might be right for
Solid TumorsAcute Myeloid LeukemiaMyelodysplastic Syndrome+1 more
Plexxikon 50
Early research (Phase 1)Study completedNCT00088868
What this trial is testing

17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Institutes of Health Clinical Center (CC) 40
Early research (Phase 1)Study completedNCT03841110
What this trial is testing

FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsLymphomaGastric Cancer+15 more
Fate Therapeutics 37
Testing effectiveness (Phase 2)UnknownNCT05320640
What this trial is testing

Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors

Who this might be right for
Relapsed/Refractory Non-Hodgkin LymphomaAdvanced Solid Tumors
Chinese PLA General Hospital 100
Early research (Phase 1)Study completedNCT00472368
What this trial is testing

Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589

Who this might be right for
Cancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological Malignancies
Novartis Pharmaceuticals 4
Early research (Phase 1)Looking for participantsNCT06615193
What this trial is testing

HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor

Who this might be right for
Advanced Solid TumorsRefractory LymphomaRelapsed Hematologic Malignancy
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 111
Early research (Phase 1)Study completedNCT00089271
What this trial is testing

17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas

Who this might be right for
Anaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+47 more
National Cancer Institute (NCI) 60
Early research (Phase 1)Looking for participantsNCT05528055
What this trial is testing

Investigate the Safety and Tolerability of SCR-6920 Capsule in Patients With Advanced Malignant Tumors

Who this might be right for
Solid TumorNon Hodgkin Lymphoma
Jiangsu Simcere Pharmaceutical Co., Ltd. 122
Early research (Phase 1)Study completedNCT01353625
What this trial is testing

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.

Who this might be right for
Glioblastoma MultiformeSquamous Cell Carcinoma of Head and NeckProstate Cancer+3 more
Celgene 118
Early research (Phase 1)Looking for participantsNCT07603479
What this trial is testing

JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Who this might be right for
MalignanciesSolid Malignant TumorNHL (Non-Hodgkin Lymphoma)+1 more
Jecho Biopharmaceuticals Co., Ltd. 14
Testing effectiveness (Phase 2)Study completedNCT03526250
What this trial is testing

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more
National Cancer Institute (NCI) 23
Early research (Phase 1)Study completedNCT00016172
What this trial is testing

ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center
Next Page